Thus, we postulate that STAT3 can be used as a therapeutic target for ovarian cancer patients and RNA interference with siRNA targeting stat3 may become an effective strategy for the treatment of ovarian cancer. This evidence concerns the gene STAT3 and ovarian cancer.